Sahm Adrangi Bets Against Bad Drugs

Sometimes the only way to fight big business is through big business itself and hedge fund investor Sahm Adrangi is always ready for a fight. The activist investor who is the Chief Investment Officer and founder of Kerrisdale Capital Management LLC. has a passion and talent for bringing to light shady business practices and even outright fraud, and he makes a profit from it. His method involves researching companies and presenting the findings for all to see through social media, news outlets, and other methods to encourage the short-selling of their stock, essentially crippling these dubious companies.


While Sahm Adrangi has expertise in betting against companies in the fields of mining and telecommunications, some of his most recent and news-worthy victories have been against big pharma and the bad drugs they were pushing that were little, if any, better than a placebo. In the latter part of 2017, 2 drugs that Adrangi had predicted the failure of did just that. They both failed in Phase III trials as Adrangi had anticipated more than a year before the Phase III trials began.


These 2 medications were a prostate cancer vaccine, one of many that have failed in recent years, and a drug to treat super-refractory status epilepticus, a rare type of epilepsy. Respectively, the medications were developed by Bavarian Nordic and Sage Therapeutics and bad science and bad testing procedures led to the development of bad drugs in which millions were wasted on development.


In light of this, things don’t look good for the latest target of Kerrisdale Capital’s short attacks: Prothena’s NEOD001 being marketed for AL amyloidosis. During his research, Sahm Adrangi suspects that all positive results are just from natural occurrences in the disease instead of the drug itself. Unfortunately for Prothena, investors are listening, and their stock dropped 8% immediately following Sahm Adrangi’s announcement. Visit This Page for related information.


The 2003 Yale University Graduate with a Bachelor of Economics Arts founded Kerrisdale Capital Management LLC. with a little under a million dollars and it now manages funds in the hundreds of millions.


More on:



Sahm Adrangi: Investor, Entrepreneur, and Researcher

Sahm Adrangi is the Chief Investment Officer (CIS) of Kerrisdale Capital Management, an investment and research management firm. Having founded the company in 2009, Adrangi is heavily involved with all of the firm’s progress and decision making. Adrangi first launched the company with less than a million dollars. Today, it manages more than $100 million.


In the industry, Sahm Adrangi is known for his short-selling and public researchers. He is motivated to educate the public on the stock market and its companies. Often, the public seems to make decisions based on misunderstandings by the overall market. Kerrisdale’s public research works towards fixing these misunderstandings. He mainly uses platforms such as Twitter and external websites.


In 2010 and 2011, Sahm Adrangi exposed multiple Chinese companies, including China Marine Food Group, Lihua International, and China-Biotics for fraudulent acts. Later, many of the companies he exposed were the subject of an investigation by the Securities and Exchange Commission (SEC). It was these initiatives that originally put his name on the market.


Sahm Adrangi’s Kerrisdale is starting to focus on three main sectors: biotechnology, mining, and telecommunications. The company believes the biotechnology sector has high potential and has published research with companies such as Sage Therapeutics, Unilife, Zafgen, Pulse Biosciences, and Bavarian Nordic; amongst others. Moreover, it has also focused heavily on the mining sector because of its possible profitability. While researching, they have questioned mining prospects of major companies, including Majestic Silver and North Dynasty Minerals. Lastly, they are heavily focused on the telecommunications sector, exposing companies like Dish Network and Globalstar for their weakness in livecast and related technical problems. Again, many of the companies called into question were the subject of investigation by the FCC. See This Article for more information.


Although Kerrisdale has played a significant role in Sahm Adrangi’s life, he is also known for taking initiatives in investments. For example, Sahm Adrangi helped a large-scale corporation with its cash flow and managed to oust two fraudulent managers at Morgans Hotel Group with two of his own. Additionally, he has been an investing speaker at various conferences throughout the nation. Moreover, Adrangi has appeared in major television networks, such as CNBC and the New York Times.